A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure

NCT05451329 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle

Interventions

DRUG: VVN539 Ophthalmic Solution 0.02%
DRUG: VVN539 Ophthalmic Solution 0.04%
DRUG: VVN539 Ophthalmic Solution Vehicle

Sponsor

VivaVision Biotech, Inc